During the last session, Korro Bio Inc (NASDAQ:KRRO)’s traded shares were 73665.0, with the beta value of the company hitting 4.53. At the end of the trading day, the stock’s price was $12.46, reflecting an intraday loss of -1.11% or -$0.14. The 52-week high for the KRRO share is $98.00, that puts it down -686.52 from that peak though still a striking 17.42% gain since the share price plummeted to a 52-week low of $10.29. The company’s market capitalization is $117.01M, and the average trade volume was 136.74K shares over the past three months.
Korro Bio Inc (KRRO) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. KRRO has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it.
Korro Bio Inc (NASDAQ:KRRO) trade information
Korro Bio Inc (KRRO) registered a -1.11% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -1.11% in intraday trading to $12.46, hitting a weekly high. The stock’s 5-day price performance is -16.21%, and it has moved by -20.69% in 30 days. Based on these gigs, the overall price performance for the year is -70.05%.
The consensus price target of analysts on Wall Street is $25, which implies an increase of 50.16% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $25 and $25 respectively. As a result, KRRO is trading at a discount of -100.64% off the target high and -100.64% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 21.83%. While earnings are projected to return -0.98% in 2025, the next five years will return -0.45% per annum.
KRRO Dividends
Korro Bio Inc is due to release its next quarterly earnings on 2025-May-07. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Korro Bio Inc (NASDAQ:KRRO)’s Major holders
Korro Bio Inc insiders own 6.19% of total outstanding shares while institutional holders control 104.41%, with the float percentage being 111.29%. ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC is the largest shareholder of the company, while 117.0 institutions own stock in it. As of 2024-06-30, the company held over 1.14 million shares (or 12.6539% of all shares), a total value of $38.52 million in shares.
The next largest institutional holding, with 1.09 million shares, is of NEA MANAGEMENT COMPANY, LLC’s that is approximately 12.1381% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $36.95 million.
